nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—Alkylating Activity—Thiotepa—urinary bladder cancer	0.504	1	CiPCiCtD
Mitomycin—POR—urinary bladder cancer	0.323	1	CbGaD
Mitomycin—POR—Doxorubicin—urinary bladder cancer	0.0798	0.686	CbGbCtD
Mitomycin—ABCB1—Gemcitabine—urinary bladder cancer	0.0107	0.0922	CbGbCtD
Mitomycin—ABCB1—Cisplatin—urinary bladder cancer	0.00779	0.067	CbGbCtD
Mitomycin—ABCB1—Etoposide—urinary bladder cancer	0.00765	0.0658	CbGbCtD
Mitomycin—ABCB1—Doxorubicin—urinary bladder cancer	0.00522	0.0449	CbGbCtD
Mitomycin—ABCB1—Methotrexate—urinary bladder cancer	0.00506	0.0435	CbGbCtD
Mitomycin—POR—prostate gland—urinary bladder cancer	0.000248	0.22	CbGeAlD
Mitomycin—POR—seminal vesicle—urinary bladder cancer	0.00021	0.186	CbGeAlD
Mitomycin—POR—urethra—urinary bladder cancer	0.000166	0.147	CbGeAlD
Mitomycin—POR—vagina—urinary bladder cancer	0.000122	0.109	CbGeAlD
Mitomycin—Extravasation—Epirubicin—urinary bladder cancer	0.000115	0.00206	CcSEcCtD
Mitomycin—Stinging—Doxorubicin—urinary bladder cancer	0.000115	0.00205	CcSEcCtD
Mitomycin—Stomatitis—Gemcitabine—urinary bladder cancer	0.000115	0.00205	CcSEcCtD
Mitomycin—Ulcer—Methotrexate—urinary bladder cancer	0.000114	0.00203	CcSEcCtD
Mitomycin—Stomatitis—Fluorouracil—urinary bladder cancer	0.000113	0.00201	CcSEcCtD
Mitomycin—Alopecia—Thiotepa—urinary bladder cancer	0.000111	0.00198	CcSEcCtD
Mitomycin—Erythema—Thiotepa—urinary bladder cancer	0.000109	0.00195	CcSEcCtD
Mitomycin—Renal failure—Cisplatin—urinary bladder cancer	0.000108	0.00192	CcSEcCtD
Mitomycin—Pancytopenia—Etoposide—urinary bladder cancer	0.000107	0.00191	CcSEcCtD
Mitomycin—Stomatitis—Cisplatin—urinary bladder cancer	0.000107	0.00191	CcSEcCtD
Mitomycin—Extravasation—Doxorubicin—urinary bladder cancer	0.000107	0.0019	CcSEcCtD
Mitomycin—Ulcer—Epirubicin—urinary bladder cancer	0.000106	0.0019	CcSEcCtD
Mitomycin—Vision blurred—Thiotepa—urinary bladder cancer	0.000103	0.00184	CcSEcCtD
Mitomycin—Anaemia—Thiotepa—urinary bladder cancer	0.000101	0.0018	CcSEcCtD
Mitomycin—Injection site reaction—Epirubicin—urinary bladder cancer	0.0001	0.00179	CcSEcCtD
Mitomycin—Renal failure—Etoposide—urinary bladder cancer	9.88e-05	0.00176	CcSEcCtD
Mitomycin—Ulcer—Doxorubicin—urinary bladder cancer	9.85e-05	0.00176	CcSEcCtD
Mitomycin—Stomatitis—Etoposide—urinary bladder cancer	9.8e-05	0.00175	CcSEcCtD
Mitomycin—Leukopenia—Thiotepa—urinary bladder cancer	9.79e-05	0.00175	CcSEcCtD
Mitomycin—Pulmonary oedema—Methotrexate—urinary bladder cancer	9.58e-05	0.00171	CcSEcCtD
Mitomycin—Cough—Thiotepa—urinary bladder cancer	9.54e-05	0.0017	CcSEcCtD
Mitomycin—Hypertension—Thiotepa—urinary bladder cancer	9.44e-05	0.00168	CcSEcCtD
Mitomycin—Alopecia—Gemcitabine—urinary bladder cancer	9.34e-05	0.00167	CcSEcCtD
Mitomycin—Injection site reaction—Doxorubicin—urinary bladder cancer	9.26e-05	0.00165	CcSEcCtD
Mitomycin—Erythema—Gemcitabine—urinary bladder cancer	9.2e-05	0.00164	CcSEcCtD
Mitomycin—Alopecia—Fluorouracil—urinary bladder cancer	9.18e-05	0.00164	CcSEcCtD
Mitomycin—Erythema—Fluorouracil—urinary bladder cancer	9.04e-05	0.00161	CcSEcCtD
Mitomycin—Thrombophlebitis—Methotrexate—urinary bladder cancer	9.03e-05	0.00161	CcSEcCtD
Mitomycin—Confusional state—Thiotepa—urinary bladder cancer	9e-05	0.0016	CcSEcCtD
Mitomycin—Pulmonary oedema—Epirubicin—urinary bladder cancer	8.97e-05	0.0016	CcSEcCtD
Mitomycin—Thrombocytopenia—Thiotepa—urinary bladder cancer	8.74e-05	0.00156	CcSEcCtD
Mitomycin—Alopecia—Cisplatin—urinary bladder cancer	8.7e-05	0.00155	CcSEcCtD
Mitomycin—Erythema—Cisplatin—urinary bladder cancer	8.57e-05	0.00153	CcSEcCtD
Mitomycin—Ill-defined disorder—Gemcitabine—urinary bladder cancer	8.54e-05	0.00152	CcSEcCtD
Mitomycin—Vision blurred—Fluorouracil—urinary bladder cancer	8.52e-05	0.00152	CcSEcCtD
Mitomycin—Anorexia—Thiotepa—urinary bladder cancer	8.51e-05	0.00152	CcSEcCtD
Mitomycin—Anaemia—Gemcitabine—urinary bladder cancer	8.5e-05	0.00152	CcSEcCtD
Mitomycin—Thrombophlebitis—Epirubicin—urinary bladder cancer	8.45e-05	0.00151	CcSEcCtD
Mitomycin—Anaemia—Fluorouracil—urinary bladder cancer	8.36e-05	0.00149	CcSEcCtD
Mitomycin—Malaise—Gemcitabine—urinary bladder cancer	8.3e-05	0.00148	CcSEcCtD
Mitomycin—Pulmonary oedema—Doxorubicin—urinary bladder cancer	8.3e-05	0.00148	CcSEcCtD
Mitomycin—Leukopenia—Gemcitabine—urinary bladder cancer	8.23e-05	0.00147	CcSEcCtD
Mitomycin—Leukopenia—Fluorouracil—urinary bladder cancer	8.1e-05	0.00144	CcSEcCtD
Mitomycin—Vision blurred—Cisplatin—urinary bladder cancer	8.08e-05	0.00144	CcSEcCtD
Mitomycin—Cardiac failure congestive—Epirubicin—urinary bladder cancer	8.06e-05	0.00144	CcSEcCtD
Mitomycin—Cough—Gemcitabine—urinary bladder cancer	8.03e-05	0.00143	CcSEcCtD
Mitomycin—Alopecia—Etoposide—urinary bladder cancer	7.97e-05	0.00142	CcSEcCtD
Mitomycin—Ill-defined disorder—Cisplatin—urinary bladder cancer	7.96e-05	0.00142	CcSEcCtD
Mitomycin—Hypertension—Gemcitabine—urinary bladder cancer	7.94e-05	0.00142	CcSEcCtD
Mitomycin—Somnolence—Thiotepa—urinary bladder cancer	7.93e-05	0.00141	CcSEcCtD
Mitomycin—Anaemia—Cisplatin—urinary bladder cancer	7.92e-05	0.00141	CcSEcCtD
Mitomycin—POR—lymph node—urinary bladder cancer	7.92e-05	0.0703	CbGeAlD
Mitomycin—Thrombophlebitis—Doxorubicin—urinary bladder cancer	7.82e-05	0.00139	CcSEcCtD
Mitomycin—Decreased appetite—Thiotepa—urinary bladder cancer	7.76e-05	0.00138	CcSEcCtD
Mitomycin—Discomfort—Gemcitabine—urinary bladder cancer	7.74e-05	0.00138	CcSEcCtD
Mitomycin—Malaise—Cisplatin—urinary bladder cancer	7.73e-05	0.00138	CcSEcCtD
Mitomycin—Fatigue—Thiotepa—urinary bladder cancer	7.69e-05	0.00137	CcSEcCtD
Mitomycin—Renal impairment—Epirubicin—urinary bladder cancer	7.68e-05	0.00137	CcSEcCtD
Mitomycin—Leukopenia—Cisplatin—urinary bladder cancer	7.67e-05	0.00137	CcSEcCtD
Mitomycin—Pain—Thiotepa—urinary bladder cancer	7.63e-05	0.00136	CcSEcCtD
Mitomycin—Discomfort—Fluorouracil—urinary bladder cancer	7.61e-05	0.00136	CcSEcCtD
Mitomycin—Oedema—Gemcitabine—urinary bladder cancer	7.51e-05	0.00134	CcSEcCtD
Mitomycin—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	7.46e-05	0.00133	CcSEcCtD
Mitomycin—Confusional state—Fluorouracil—urinary bladder cancer	7.44e-05	0.00133	CcSEcCtD
Mitomycin—Oedema—Fluorouracil—urinary bladder cancer	7.38e-05	0.00132	CcSEcCtD
Mitomycin—Feeling abnormal—Thiotepa—urinary bladder cancer	7.35e-05	0.00131	CcSEcCtD
Mitomycin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	7.35e-05	0.00131	CcSEcCtD
Mitomycin—Ill-defined disorder—Etoposide—urinary bladder cancer	7.29e-05	0.0013	CcSEcCtD
Mitomycin—Anaemia—Etoposide—urinary bladder cancer	7.26e-05	0.00129	CcSEcCtD
Mitomycin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	7.23e-05	0.00129	CcSEcCtD
Mitomycin—Discomfort—Cisplatin—urinary bladder cancer	7.21e-05	0.00129	CcSEcCtD
Mitomycin—Anorexia—Gemcitabine—urinary bladder cancer	7.16e-05	0.00128	CcSEcCtD
Mitomycin—Renal impairment—Doxorubicin—urinary bladder cancer	7.11e-05	0.00127	CcSEcCtD
Mitomycin—Malaise—Etoposide—urinary bladder cancer	7.08e-05	0.00126	CcSEcCtD
Mitomycin—Body temperature increased—Thiotepa—urinary bladder cancer	7.06e-05	0.00126	CcSEcCtD
Mitomycin—Anorexia—Fluorouracil—urinary bladder cancer	7.04e-05	0.00125	CcSEcCtD
Mitomycin—Leukopenia—Etoposide—urinary bladder cancer	7.03e-05	0.00125	CcSEcCtD
Mitomycin—Oedema—Cisplatin—urinary bladder cancer	7e-05	0.00125	CcSEcCtD
Mitomycin—Loss of consciousness—Etoposide—urinary bladder cancer	6.9e-05	0.00123	CcSEcCtD
Mitomycin—Cough—Etoposide—urinary bladder cancer	6.85e-05	0.00122	CcSEcCtD
Mitomycin—Thrombocytopenia—Cisplatin—urinary bladder cancer	6.85e-05	0.00122	CcSEcCtD
Mitomycin—Hypertension—Etoposide—urinary bladder cancer	6.78e-05	0.00121	CcSEcCtD
Mitomycin—Dyspnoea—Gemcitabine—urinary bladder cancer	6.69e-05	0.00119	CcSEcCtD
Mitomycin—Somnolence—Gemcitabine—urinary bladder cancer	6.67e-05	0.00119	CcSEcCtD
Mitomycin—Anorexia—Cisplatin—urinary bladder cancer	6.67e-05	0.00119	CcSEcCtD
Mitomycin—Discomfort—Etoposide—urinary bladder cancer	6.61e-05	0.00118	CcSEcCtD
Mitomycin—Dyspnoea—Fluorouracil—urinary bladder cancer	6.58e-05	0.00117	CcSEcCtD
Mitomycin—Somnolence—Fluorouracil—urinary bladder cancer	6.56e-05	0.00117	CcSEcCtD
Mitomycin—Decreased appetite—Gemcitabine—urinary bladder cancer	6.53e-05	0.00116	CcSEcCtD
Mitomycin—Fatigue—Gemcitabine—urinary bladder cancer	6.47e-05	0.00115	CcSEcCtD
Mitomycin—Confusional state—Etoposide—urinary bladder cancer	6.46e-05	0.00115	CcSEcCtD
Mitomycin—Pain—Gemcitabine—urinary bladder cancer	6.42e-05	0.00114	CcSEcCtD
Mitomycin—Decreased appetite—Fluorouracil—urinary bladder cancer	6.42e-05	0.00114	CcSEcCtD
Mitomycin—Pancytopenia—Methotrexate—urinary bladder cancer	6.41e-05	0.00114	CcSEcCtD
Mitomycin—Asthenia—Thiotepa—urinary bladder cancer	6.4e-05	0.00114	CcSEcCtD
Mitomycin—Pain—Fluorouracil—urinary bladder cancer	6.31e-05	0.00113	CcSEcCtD
Mitomycin—Thrombocytopenia—Etoposide—urinary bladder cancer	6.28e-05	0.00112	CcSEcCtD
Mitomycin—Dyspnoea—Cisplatin—urinary bladder cancer	6.24e-05	0.00111	CcSEcCtD
Mitomycin—Feeling abnormal—Gemcitabine—urinary bladder cancer	6.19e-05	0.0011	CcSEcCtD
Mitomycin—Anorexia—Etoposide—urinary bladder cancer	6.11e-05	0.00109	CcSEcCtD
Mitomycin—Diarrhoea—Thiotepa—urinary bladder cancer	6.11e-05	0.00109	CcSEcCtD
Mitomycin—Decreased appetite—Cisplatin—urinary bladder cancer	6.08e-05	0.00108	CcSEcCtD
Mitomycin—Feeling abnormal—Fluorouracil—urinary bladder cancer	6.08e-05	0.00108	CcSEcCtD
Mitomycin—Drowsiness—Methotrexate—urinary bladder cancer	6.02e-05	0.00107	CcSEcCtD
Mitomycin—Pancytopenia—Epirubicin—urinary bladder cancer	6e-05	0.00107	CcSEcCtD
Mitomycin—Pain—Cisplatin—urinary bladder cancer	5.98e-05	0.00107	CcSEcCtD
Mitomycin—Body temperature increased—Gemcitabine—urinary bladder cancer	5.93e-05	0.00106	CcSEcCtD
Mitomycin—Renal failure—Methotrexate—urinary bladder cancer	5.92e-05	0.00106	CcSEcCtD
Mitomycin—Dizziness—Thiotepa—urinary bladder cancer	5.9e-05	0.00105	CcSEcCtD
Mitomycin—Stomatitis—Methotrexate—urinary bladder cancer	5.87e-05	0.00105	CcSEcCtD
Mitomycin—Body temperature increased—Fluorouracil—urinary bladder cancer	5.84e-05	0.00104	CcSEcCtD
Mitomycin—Feeling abnormal—Cisplatin—urinary bladder cancer	5.77e-05	0.00103	CcSEcCtD
Mitomycin—Dyspnoea—Etoposide—urinary bladder cancer	5.72e-05	0.00102	CcSEcCtD
Mitomycin—Somnolence—Etoposide—urinary bladder cancer	5.7e-05	0.00102	CcSEcCtD
Mitomycin—ABCB1—prostate gland—urinary bladder cancer	5.68e-05	0.0505	CbGeAlD
Mitomycin—Vomiting—Thiotepa—urinary bladder cancer	5.67e-05	0.00101	CcSEcCtD
Mitomycin—Drowsiness—Epirubicin—urinary bladder cancer	5.63e-05	0.001	CcSEcCtD
Mitomycin—Rash—Thiotepa—urinary bladder cancer	5.63e-05	0.001	CcSEcCtD
Mitomycin—Dermatitis—Thiotepa—urinary bladder cancer	5.62e-05	0.001	CcSEcCtD
Mitomycin—Headache—Thiotepa—urinary bladder cancer	5.59e-05	0.000997	CcSEcCtD
Mitomycin—Decreased appetite—Etoposide—urinary bladder cancer	5.57e-05	0.000994	CcSEcCtD
Mitomycin—Pancytopenia—Doxorubicin—urinary bladder cancer	5.55e-05	0.00099	CcSEcCtD
Mitomycin—Renal failure—Epirubicin—urinary bladder cancer	5.54e-05	0.000988	CcSEcCtD
Mitomycin—Body temperature increased—Cisplatin—urinary bladder cancer	5.53e-05	0.000986	CcSEcCtD
Mitomycin—Fatigue—Etoposide—urinary bladder cancer	5.53e-05	0.000986	CcSEcCtD
Mitomycin—Stomatitis—Epirubicin—urinary bladder cancer	5.49e-05	0.000979	CcSEcCtD
Mitomycin—Pain—Etoposide—urinary bladder cancer	5.48e-05	0.000978	CcSEcCtD
Mitomycin—Asthenia—Gemcitabine—urinary bladder cancer	5.39e-05	0.000961	CcSEcCtD
Mitomycin—Nausea—Thiotepa—urinary bladder cancer	5.3e-05	0.000945	CcSEcCtD
Mitomycin—Feeling abnormal—Etoposide—urinary bladder cancer	5.28e-05	0.000942	CcSEcCtD
Mitomycin—Drowsiness—Doxorubicin—urinary bladder cancer	5.21e-05	0.00093	CcSEcCtD
Mitomycin—Diarrhoea—Gemcitabine—urinary bladder cancer	5.14e-05	0.000916	CcSEcCtD
Mitomycin—Renal failure—Doxorubicin—urinary bladder cancer	5.12e-05	0.000914	CcSEcCtD
Mitomycin—Stomatitis—Doxorubicin—urinary bladder cancer	5.08e-05	0.000906	CcSEcCtD
Mitomycin—Body temperature increased—Etoposide—urinary bladder cancer	5.07e-05	0.000904	CcSEcCtD
Mitomycin—Diarrhoea—Fluorouracil—urinary bladder cancer	5.05e-05	0.000901	CcSEcCtD
Mitomycin—Asthenia—Cisplatin—urinary bladder cancer	5.02e-05	0.000895	CcSEcCtD
Mitomycin—Dizziness—Fluorouracil—urinary bladder cancer	4.88e-05	0.00087	CcSEcCtD
Mitomycin—ABCB1—seminal vesicle—urinary bladder cancer	4.81e-05	0.0427	CbGeAlD
Mitomycin—Diarrhoea—Cisplatin—urinary bladder cancer	4.79e-05	0.000854	CcSEcCtD
Mitomycin—Alopecia—Methotrexate—urinary bladder cancer	4.78e-05	0.000852	CcSEcCtD
Mitomycin—Vomiting—Gemcitabine—urinary bladder cancer	4.77e-05	0.000851	CcSEcCtD
Mitomycin—Rash—Gemcitabine—urinary bladder cancer	4.73e-05	0.000844	CcSEcCtD
Mitomycin—Dermatitis—Gemcitabine—urinary bladder cancer	4.73e-05	0.000843	CcSEcCtD
Mitomycin—Erythema—Methotrexate—urinary bladder cancer	4.71e-05	0.000839	CcSEcCtD
Mitomycin—Headache—Gemcitabine—urinary bladder cancer	4.7e-05	0.000839	CcSEcCtD
Mitomycin—Vomiting—Fluorouracil—urinary bladder cancer	4.69e-05	0.000837	CcSEcCtD
Mitomycin—Rash—Fluorouracil—urinary bladder cancer	4.65e-05	0.00083	CcSEcCtD
Mitomycin—Dermatitis—Fluorouracil—urinary bladder cancer	4.65e-05	0.000829	CcSEcCtD
Mitomycin—Headache—Fluorouracil—urinary bladder cancer	4.62e-05	0.000825	CcSEcCtD
Mitomycin—Asthenia—Etoposide—urinary bladder cancer	4.6e-05	0.00082	CcSEcCtD
Mitomycin—Alopecia—Epirubicin—urinary bladder cancer	4.47e-05	0.000797	CcSEcCtD
Mitomycin—Nausea—Gemcitabine—urinary bladder cancer	4.46e-05	0.000795	CcSEcCtD
Mitomycin—Vomiting—Cisplatin—urinary bladder cancer	4.45e-05	0.000793	CcSEcCtD
Mitomycin—Vision blurred—Methotrexate—urinary bladder cancer	4.43e-05	0.000791	CcSEcCtD
Mitomycin—Rash—Cisplatin—urinary bladder cancer	4.41e-05	0.000787	CcSEcCtD
Mitomycin—Dermatitis—Cisplatin—urinary bladder cancer	4.41e-05	0.000786	CcSEcCtD
Mitomycin—Erythema—Epirubicin—urinary bladder cancer	4.4e-05	0.000785	CcSEcCtD
Mitomycin—Diarrhoea—Etoposide—urinary bladder cancer	4.39e-05	0.000782	CcSEcCtD
Mitomycin—Nausea—Fluorouracil—urinary bladder cancer	4.38e-05	0.000782	CcSEcCtD
Mitomycin—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.37e-05	0.000779	CcSEcCtD
Mitomycin—Anaemia—Methotrexate—urinary bladder cancer	4.35e-05	0.000776	CcSEcCtD
Mitomycin—Malaise—Methotrexate—urinary bladder cancer	4.24e-05	0.000757	CcSEcCtD
Mitomycin—Dizziness—Etoposide—urinary bladder cancer	4.24e-05	0.000756	CcSEcCtD
Mitomycin—Leukopenia—Methotrexate—urinary bladder cancer	4.21e-05	0.000751	CcSEcCtD
Mitomycin—ABCB1—epithelium—urinary bladder cancer	4.18e-05	0.0371	CbGeAlD
Mitomycin—Nausea—Cisplatin—urinary bladder cancer	4.16e-05	0.000741	CcSEcCtD
Mitomycin—Vision blurred—Epirubicin—urinary bladder cancer	4.15e-05	0.00074	CcSEcCtD
Mitomycin—Alopecia—Doxorubicin—urinary bladder cancer	4.14e-05	0.000738	CcSEcCtD
Mitomycin—Cough—Methotrexate—urinary bladder cancer	4.11e-05	0.000732	CcSEcCtD
Mitomycin—Ill-defined disorder—Epirubicin—urinary bladder cancer	4.09e-05	0.000729	CcSEcCtD
Mitomycin—Vomiting—Etoposide—urinary bladder cancer	4.08e-05	0.000727	CcSEcCtD
Mitomycin—Erythema—Doxorubicin—urinary bladder cancer	4.07e-05	0.000727	CcSEcCtD
Mitomycin—Anaemia—Epirubicin—urinary bladder cancer	4.07e-05	0.000726	CcSEcCtD
Mitomycin—Rash—Etoposide—urinary bladder cancer	4.04e-05	0.000721	CcSEcCtD
Mitomycin—Dermatitis—Etoposide—urinary bladder cancer	4.04e-05	0.00072	CcSEcCtD
Mitomycin—Headache—Etoposide—urinary bladder cancer	4.02e-05	0.000716	CcSEcCtD
Mitomycin—Malaise—Epirubicin—urinary bladder cancer	3.97e-05	0.000708	CcSEcCtD
Mitomycin—Discomfort—Methotrexate—urinary bladder cancer	3.96e-05	0.000706	CcSEcCtD
Mitomycin—Syncope—Epirubicin—urinary bladder cancer	3.95e-05	0.000704	CcSEcCtD
Mitomycin—Leukopenia—Epirubicin—urinary bladder cancer	3.94e-05	0.000703	CcSEcCtD
Mitomycin—ABCB1—renal system—urinary bladder cancer	3.87e-05	0.0344	CbGeAlD
Mitomycin—Confusional state—Methotrexate—urinary bladder cancer	3.87e-05	0.00069	CcSEcCtD
Mitomycin—Loss of consciousness—Epirubicin—urinary bladder cancer	3.87e-05	0.00069	CcSEcCtD
Mitomycin—Cough—Epirubicin—urinary bladder cancer	3.84e-05	0.000685	CcSEcCtD
Mitomycin—Vision blurred—Doxorubicin—urinary bladder cancer	3.84e-05	0.000685	CcSEcCtD
Mitomycin—Nausea—Etoposide—urinary bladder cancer	3.81e-05	0.000679	CcSEcCtD
Mitomycin—ABCB1—urethra—urinary bladder cancer	3.8e-05	0.0338	CbGeAlD
Mitomycin—Hypertension—Epirubicin—urinary bladder cancer	3.8e-05	0.000678	CcSEcCtD
Mitomycin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.78e-05	0.000674	CcSEcCtD
Mitomycin—Anaemia—Doxorubicin—urinary bladder cancer	3.77e-05	0.000672	CcSEcCtD
Mitomycin—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.76e-05	0.00067	CcSEcCtD
Mitomycin—Discomfort—Epirubicin—urinary bladder cancer	3.7e-05	0.00066	CcSEcCtD
Mitomycin—Malaise—Doxorubicin—urinary bladder cancer	3.67e-05	0.000655	CcSEcCtD
Mitomycin—Anorexia—Methotrexate—urinary bladder cancer	3.66e-05	0.000653	CcSEcCtD
Mitomycin—Syncope—Doxorubicin—urinary bladder cancer	3.65e-05	0.000652	CcSEcCtD
Mitomycin—Leukopenia—Doxorubicin—urinary bladder cancer	3.65e-05	0.00065	CcSEcCtD
Mitomycin—Confusional state—Epirubicin—urinary bladder cancer	3.62e-05	0.000646	CcSEcCtD
Mitomycin—Oedema—Epirubicin—urinary bladder cancer	3.59e-05	0.000641	CcSEcCtD
Mitomycin—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.58e-05	0.000639	CcSEcCtD
Mitomycin—Cough—Doxorubicin—urinary bladder cancer	3.56e-05	0.000634	CcSEcCtD
Mitomycin—Shock—Epirubicin—urinary bladder cancer	3.54e-05	0.00063	CcSEcCtD
Mitomycin—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.52e-05	0.000627	CcSEcCtD
Mitomycin—Hypertension—Doxorubicin—urinary bladder cancer	3.52e-05	0.000627	CcSEcCtD
Mitomycin—Discomfort—Doxorubicin—urinary bladder cancer	3.43e-05	0.000611	CcSEcCtD
Mitomycin—Anorexia—Epirubicin—urinary bladder cancer	3.43e-05	0.000611	CcSEcCtD
Mitomycin—Dyspnoea—Methotrexate—urinary bladder cancer	3.42e-05	0.000611	CcSEcCtD
Mitomycin—Somnolence—Methotrexate—urinary bladder cancer	3.41e-05	0.000609	CcSEcCtD
Mitomycin—Confusional state—Doxorubicin—urinary bladder cancer	3.35e-05	0.000598	CcSEcCtD
Mitomycin—Decreased appetite—Methotrexate—urinary bladder cancer	3.34e-05	0.000595	CcSEcCtD
Mitomycin—Oedema—Doxorubicin—urinary bladder cancer	3.33e-05	0.000593	CcSEcCtD
Mitomycin—Fatigue—Methotrexate—urinary bladder cancer	3.31e-05	0.00059	CcSEcCtD
Mitomycin—Pain—Methotrexate—urinary bladder cancer	3.28e-05	0.000586	CcSEcCtD
Mitomycin—Shock—Doxorubicin—urinary bladder cancer	3.27e-05	0.000583	CcSEcCtD
Mitomycin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.26e-05	0.000581	CcSEcCtD
Mitomycin—Dyspnoea—Epirubicin—urinary bladder cancer	3.2e-05	0.000571	CcSEcCtD
Mitomycin—Somnolence—Epirubicin—urinary bladder cancer	3.19e-05	0.00057	CcSEcCtD
Mitomycin—Anorexia—Doxorubicin—urinary bladder cancer	3.17e-05	0.000565	CcSEcCtD
Mitomycin—Feeling abnormal—Methotrexate—urinary bladder cancer	3.16e-05	0.000564	CcSEcCtD
Mitomycin—Decreased appetite—Epirubicin—urinary bladder cancer	3.12e-05	0.000557	CcSEcCtD
Mitomycin—ABCB1—female reproductive system—urinary bladder cancer	3.1e-05	0.0275	CbGeAlD
Mitomycin—Fatigue—Epirubicin—urinary bladder cancer	3.1e-05	0.000553	CcSEcCtD
Mitomycin—Pain—Epirubicin—urinary bladder cancer	3.07e-05	0.000548	CcSEcCtD
Mitomycin—Body temperature increased—Methotrexate—urinary bladder cancer	3.04e-05	0.000541	CcSEcCtD
Mitomycin—Dyspnoea—Doxorubicin—urinary bladder cancer	2.96e-05	0.000529	CcSEcCtD
Mitomycin—Feeling abnormal—Epirubicin—urinary bladder cancer	2.96e-05	0.000528	CcSEcCtD
Mitomycin—Somnolence—Doxorubicin—urinary bladder cancer	2.96e-05	0.000527	CcSEcCtD
Mitomycin—Decreased appetite—Doxorubicin—urinary bladder cancer	2.89e-05	0.000515	CcSEcCtD
Mitomycin—Fatigue—Doxorubicin—urinary bladder cancer	2.87e-05	0.000511	CcSEcCtD
Mitomycin—Pain—Doxorubicin—urinary bladder cancer	2.84e-05	0.000507	CcSEcCtD
Mitomycin—Body temperature increased—Epirubicin—urinary bladder cancer	2.84e-05	0.000507	CcSEcCtD
Mitomycin—ABCB1—vagina—urinary bladder cancer	2.81e-05	0.0249	CbGeAlD
Mitomycin—Asthenia—Methotrexate—urinary bladder cancer	2.76e-05	0.000491	CcSEcCtD
Mitomycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.74e-05	0.000489	CcSEcCtD
Mitomycin—Body temperature increased—Doxorubicin—urinary bladder cancer	2.63e-05	0.000469	CcSEcCtD
Mitomycin—Diarrhoea—Methotrexate—urinary bladder cancer	2.63e-05	0.000469	CcSEcCtD
Mitomycin—Asthenia—Epirubicin—urinary bladder cancer	2.58e-05	0.00046	CcSEcCtD
Mitomycin—Dizziness—Methotrexate—urinary bladder cancer	2.54e-05	0.000453	CcSEcCtD
Mitomycin—Diarrhoea—Epirubicin—urinary bladder cancer	2.46e-05	0.000438	CcSEcCtD
Mitomycin—Vomiting—Methotrexate—urinary bladder cancer	2.44e-05	0.000435	CcSEcCtD
Mitomycin—Rash—Methotrexate—urinary bladder cancer	2.42e-05	0.000432	CcSEcCtD
Mitomycin—Dermatitis—Methotrexate—urinary bladder cancer	2.42e-05	0.000431	CcSEcCtD
Mitomycin—Headache—Methotrexate—urinary bladder cancer	2.41e-05	0.000429	CcSEcCtD
Mitomycin—Asthenia—Doxorubicin—urinary bladder cancer	2.39e-05	0.000425	CcSEcCtD
Mitomycin—Dizziness—Epirubicin—urinary bladder cancer	2.38e-05	0.000424	CcSEcCtD
Mitomycin—Vomiting—Epirubicin—urinary bladder cancer	2.28e-05	0.000407	CcSEcCtD
Mitomycin—Nausea—Methotrexate—urinary bladder cancer	2.28e-05	0.000407	CcSEcCtD
Mitomycin—Diarrhoea—Doxorubicin—urinary bladder cancer	2.28e-05	0.000406	CcSEcCtD
Mitomycin—Rash—Epirubicin—urinary bladder cancer	2.27e-05	0.000404	CcSEcCtD
Mitomycin—Dermatitis—Epirubicin—urinary bladder cancer	2.26e-05	0.000404	CcSEcCtD
Mitomycin—Headache—Epirubicin—urinary bladder cancer	2.25e-05	0.000401	CcSEcCtD
Mitomycin—Dizziness—Doxorubicin—urinary bladder cancer	2.2e-05	0.000392	CcSEcCtD
Mitomycin—Nausea—Epirubicin—urinary bladder cancer	2.13e-05	0.000381	CcSEcCtD
Mitomycin—Vomiting—Doxorubicin—urinary bladder cancer	2.11e-05	0.000377	CcSEcCtD
Mitomycin—Rash—Doxorubicin—urinary bladder cancer	2.1e-05	0.000374	CcSEcCtD
Mitomycin—Dermatitis—Doxorubicin—urinary bladder cancer	2.09e-05	0.000374	CcSEcCtD
Mitomycin—Headache—Doxorubicin—urinary bladder cancer	2.08e-05	0.000371	CcSEcCtD
Mitomycin—Nausea—Doxorubicin—urinary bladder cancer	1.98e-05	0.000352	CcSEcCtD
Mitomycin—ABCB1—lymph node—urinary bladder cancer	1.81e-05	0.0161	CbGeAlD
